Valuation: Pfizer Inc

Market Cap 143B 125B 115B 106B 200B 13,749B 204B 1,376B 541B 6,734B 536B 524B 23,181B P/E 2026 *
12.7x
P/E 2027 * 13.2x
Enterprise Value 192B 168B 155B 143B 269B 18,497B 275B 1,851B 728B 9,059B 721B 705B 31,185B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 3.14x
Free-Float
59.06%
Yield 2026 *
6.89%
Yield 2027 * 6.96%

Last Transcript: Pfizer Inc

Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 60 2022-05-01
Chief Tech/Sci/R&D Officer - 2006-12-31
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%-0.80%+52.79%+159.97% 1,051B
+1.23%-1.53%+54.58%+59.41% 609B
+0.04%+2.58%+34.47%+84.84% 450B
+0.78%-0.71%+29.28%+23.25% 330B
+1.41%+0.58%+35.44%+40.53% 284B
-0.27%-1.87%+22.34%+19.92% 263B
-1.76%+2.37%-20.43%-38.01% 223B
-1.42%+0.80%+24.27%+57.85% 198B
-1.48%+3.43%+24.08%+70.06% 167B
Average -0.07%+0.54%+28.54%+53.09% 397.23B
Weighted average by Cap. +0.37%+0.02%+37.51%+78.76%

Financials

2026 *2027 *
Net sales 61.74B 53.95B 49.79B 45.89B 86.49B 5,945B 88.41B 595B 234B 2,912B 232B 227B 10,024B 59.2B 51.73B 47.74B 44B 82.94B 5,701B 84.78B 571B 224B 2,792B 222B 217B 9,612B
Net income 10.63B 9.29B 8.57B 7.9B 14.89B 1,023B 15.22B 102B 40.29B 501B 39.91B 39.03B 1,725B 10.27B 8.97B 8.28B 7.63B 14.39B 989B 14.7B 98.97B 38.93B 484B 38.56B 37.71B 1,667B
Net Debt 49.3B 43.08B 39.75B 36.64B 69.07B 4,747B 70.6B 475B 187B 2,325B 185B 181B 8,004B 43.17B 37.72B 34.81B 32.09B 60.48B 4,157B 61.82B 416B 164B 2,036B 162B 159B 7,009B
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-